Complementary therapies: evaluating their effectiveness in cancer
Journal/Book: Patient Educ Couns. 1999; 38: Customer Relations Manager Bay 15, Shannon Industrial Estate CO, Clare, Ireland. Elsevier Sci Ireland Ltd. 101-108.
Abstract: The use of complementary therapies is common among cancer patients. However, a major concern is that very few of these therapies have been appropriately evaluated and, thus, Little is known about their safety and efficacy. The gold standard for evaluating cancer treatments is the randomized controlled trial (RCT). However, there are several issues inherent to the nature and practice of complementary therapies that interfere with the straightforward use of RCTs. Alternative approaches are often highly individualized and attempt to respond to patients' needs. They are often holistic, taking into account many facets of a patient's life. Placebo effects and the role of the provider are frequently recognized as an important part of treatment. Outcomes of complementary therapies are often subjective, rather than being more objective outcomes, such as increased survival time. Although it is important to evaluate complementary therapies, it is mandatory that studies be sensitive to these issues and that existing research methods be adjusted and modified for this purpose.
Note: Article Hilsden RJ, Univ Calgary, Dept Community Hlth Sci, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, CANADA
Keyword(s): complementary and alternative medicine; cancer; randomized controlled trials; RANDOMIZED CONTROLLED TRIALS; ALTERNATIVE MEDICINE; UNCONVENTIONAL THERAPIES; CLINICAL-TRIALS; BACK-PAIN; ACUPUNCTURE; ONCOLOGY